Custom Synthesis

Introduction: Automation in Peptide-Oligonucleotide Conjugate Synthesis is becoming increasingly important as researchers seek more reproducible and scalable ways to manufacture […]

Introduction Peptide-Oligonucleotide Conjugate Drug Product Formulation Services address the complex development transition between bulk active pharmaceutical ingredient (API) bioconjugation and

Introduction Peptide-oligonucleotide conjugates depend on Next-Generation Oligonucleotide Chemistries to address the limitations associated with native enzymatic degradation, inadequate cellular permeability,

Introduction The use of Peptide-Oligonucleotide Conjugate (POCs) in CNS Drug Delivery represents an advanced bioconjugation strategy designed to transport therapeutic

Introduction Maintaining effective Peptide Oligonucleotide Conjugate Storage Stability Handling requires strict control of environmental conditions and adherence to carefully designed

Introduction The optimization of Purification Techniques for Peptide-Oligonucleotide Conjugates depends on the strategic application of orthogonal chromatographic methodologies capable of

Introduction Peptide-oligonucleotide conjugates gain entry into cells mainly through energy-dependent endocytosis or energy-independent direct plasma membrane translocation, with the dominant

Introduction: Anyone comparing an antisense oligonucleotide vs peptide-oligonucleotide conjugate is really asking a structural question: is the therapeutic molecule a

Introduction Endosomal Escape in Peptide Oligonucleotide Conjugates (POC) Therapeutics refers to the physical translocation of synthetic nucleic acid-peptide chimeras from